Alzheimer's disease - clinical testing

Professor Donna Wilcock explains that Alzheimer's disease is diagnosed clinically by a battery of tests that can take a full day to administer.

Alzheimer’s disease is diagnosed clinically, right now, by a battery of memory tests that are administered typically by a neurologist who is running a memory clinic. These memory tests can take a full day, basically, of different types of memory and recall – maybe telling you a story when you first walk into the clinic and then asking you to recall it a couple hours later. All of these tests test very slightly different mechanisms of memory in different parts of the brain. Based on these, there are some patterns you see that really indicate that yes this really is Alzheimer’s [disease], or no it is different, as there are many other different types of dementia.

alzheimer, disease, diagnosis, clinical, clinic, memory, tests, psychometric, dementia, donna, wilcock

Related Content

2187. Alzheimer's disease - imaging test

Professor Donna Wilcock discusses a new biological technique for diagnosing Alzheimer's disease using PET neuroimaging.

  • ID: 2187
  • Source: G2C

2182. Alzheimer's disease therapy - clinical trials

Professor Donna Wilcock discusses the process of going from a mouse model to human trials for testing the amyloid beta immunization for Alzheimer's disease.

  • ID: 2182
  • Source: G2C

2179. Alzheimer's disease neuropathology - stages

Professor Donna Wilcock describes the neuropathology of Alzheimer's disease as it progresses from the hippocampus to other brain areas.

  • ID: 2179
  • Source: G2C

2227. Alzheimer's disease

An overview of Alzheimer's disease-related content on Genes to Cognition Online.

  • ID: 2227
  • Source: G2C

2184. Education fights Alzheimers disease?

Professor Donna Wilcock discusses research that correlates higher education levels with Alzheimer's disease prevention. This finding has not been fully supported.

  • ID: 2184
  • Source: G2C

2175. Alzheimer's disease medications - Aricept

Professor Donna Wilcock explains that Aricept can only provide short-term benefit in treating Alzheimer's disease.

  • ID: 2175
  • Source: G2C

2177. Cholinergic hypothesis of Alzheimer’s disease

Professor Donna Wilcock dscusses the cholinergic hypothesis of Alzheimer's disease, which focuses on cholinergic neurons. The hypothesis has not been supported.

  • ID: 2177
  • Source: G2C

2174. Neuron loss

Professor Donna Wilcock describes how neurofibrillary tangles choke neurons, causing them to die. This is one of three hallmarks of Alzheimer's disease.

  • ID: 2174
  • Source: G2C

2188. Early-onset Alzheimer's disease, 30-65

Professor Donna Wilcock discusses early-onset Alzheimer's disease, which can reach an advanced stage by the age of 50 or 60 years.

  • ID: 2188
  • Source: G2C

2183. Alzheimer's disease statistics - prevalence and age

Professor Donna Wilcock discusses Alzheimer's disease in the light of increasing prevalence as the population ages.

  • ID: 2183
  • Source: G2C